Jason Miska

24PUBLICATIONS
127CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Medical infection agents (incl. prions)Gene and molecular therapyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 26, 2026
Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205.

|Mar 17, 2026
Microglial fructose metabolism is essential for glioblastoma growth.

Leah K Billingham, Susan L DeLay, Yasmina Eshac

|Feb 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.

Mark W Youngblood, Shashwat Tripathi, Hinda Najem

|Nov 03, 2025
cGAS-agonistic spherical nucleic acids reprogram the glioblastoma immune microenvironment and promote antitumor immunity.

Akanksha S Mahajan, Corey Dussold, Seunghyun Kim

|Oct 28, 2025
Bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodeling in immune-competent preclinical models.

Markella Zannikou, Joseph T Duffy, Daniele Procissi

Pageof 4